Uncategorized
Efficacy primary consideration with adjunctive therapies, survey finds
The majority of glaucoma specialists reported that efficacy was most important when prescribing adjunctive therapies for glaucoma when compared to tolerability, safety and insurance coverage, according to a recently released survey.Results of the 2014 MS Global Research Survey of Glaucoma Specialists, which was sponsored by Allergan, were released at the end of August.